Clinical trial
A Pilot Study of Telitacicept Treatment in Primary APS Patients
NCT05078710 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Telitacicept Treatment in Primary APS Patients
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 1, 2021
- Completion date
- June 1, 2025
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti phospholipid syndrome